Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients-Reference-Cited by-同舟云学术

Early treatment outcome of bedaquiline plus optimised background regimen in drug resistant tuberculosis patients

Published:2020-04 Issue:2 Volume:67 Page:222-230
ISSN:0019-5707
Container-title:Indian Journal of Tuberculosis
language:en
Short-container-title:Indian Journal of Tuberculosis

Author:

Barvaliya Sandip V.,Desai Mira K.,Panchal Jigar R.,Solanki Rajesh N.

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference22 articles.

1. Global Tuberculosis Report;World Health Organization,2017

2. ‘First National Tuberculosis Drug Resistance Survey in India’ Available from: https://tbcindia.gov.in/showfile.php?lid=3315 (accessed on 29 July 2019).

3. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis;Jain;J Pharmacol Pharmacother,2014

4. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis;Steingart;PLoS Med,2011

5. QTc prolongation and treatment of multidrug-resistant Tuberculosis;Harausz;Int J Tuberc Lung Dis,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of bedaquiline containing all oral longer regimens in treating multidrug/rifampicin resistant tuberculosis in Pakistan;Journal of Infection and Public Health;2024-09

2. Impact of bedaquiline regimen on the treatment success rates of multidrug-resistant tuberculosis patients in Egypt;Scientific Reports;2024-07-15

3. Bedaquiline and delamanid treatment outcomes among patients with drug-resistant tuberculosis: a systematic review and meta-analysis;Minerva Respiratory Medicine;2024-03

4. Bedaquiline’s Safety Profile Monitoring in India: Considerations for Future - A Systematic Review;Current Drug Safety;2024-02

5. Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-02